Skip to main content

Opus Genetics, Inc.

IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001228627

In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 6 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Opus Genetics, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of IRD: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders43146+4
Shares3.68M16.6K14.6M+10.9M (+297.6%)
Value$4.38M$19.7K$14.7M+$10.3M (+237.0%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (14)

Institutions that held Opus Genetics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to IRD in Q1 2025
InstitutionSharesValue% of portfolio
Perceptive Advisors LLC4,325,000$4.25M0.15%
Nantahala Capital Management, LLC3,157,895$3.10M0.26%
Opaleye Management Inc.1,175,000$1.55M0.34%
Mink Brook Asset Management LLC810,080$795.3K0.84%
Bleichroeder LP736,842$723.4K0.19%
AWM Investment Company, Inc.524,245$514.7K0.07%
Virtu Financial LLC26,275$26.0K0.00%
Susquehanna International Group, LLP23,099$22.7K0.00%
Sofos Investments, Inc.16,555$16.3K0.00%
HRT Financial LP15,168$14.0K0.00%
Warberg Asset Management LLC10,000$9.82K0.00%
Barclays PLC1,900$1.86K0.00%
Simplex Trading, LLC1,618$1.00K0.00%
JPMorgan Chase & Co58$570.00%

Sold out (10)

Institutions that held Opus Genetics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of IRD in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
XTX Topco Ltd43,578$51.9K
Diametric Capital, LP29,299$34.9K
Jane Street Group, LLC18,353$21.8K
Two Sigma Securities, LLC16,202$19.3K
Millennium Management LLC11,991$14.3K
Tower Research Capital LLC (TRC)4,088$4.87K
Richards, Merrill & Peterson, Inc.70$83
Knoll Capital Management, LLC45$53
Northwestern Mutual Wealth Management Co10$12
FMR LLC1$1

Not filed for Q1 2025 yet (1)

Institutions that held Opus Genetics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IRD in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Financial Gravity Companies, Inc.16,555$19.7K